Myriad Genetics Inc (MYGN): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 4,05 US Dollar | 1 | 0 | 5 | 2 | 1 |
| #Shares | Short [%] | Short Ratio |
| 95.649.645 | 9,16 | 4,09 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Myriad Genetics Inc
Mitarbeiter 2.700
Handelsplatz NASDAQ
Ticker Symbol MYGN
IPO Datum 1995-10-05
Adresse 322 North 2200 West, Salt Lake City, UT, United States, 84116
Webseite https://www.myriad.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Samraat S. Raha | President, CEO & Director |
| 2 | Mr. Benjamin R. Wheeler | CFO & Principal Accounting Officer |
| 3 | Mr. Mark S. Verratti | Chief Operating Officer |
| 4 | Dr. Dale Muzzey Ph.D. | Chief Scientific Officer |
| 5 | Mr. Paul J. Diaz J.D. | Consultant |
| 6 | Mr. Raj Jampa | Chief Technology Officer |
| 7 | Mr. Matthew Scalo | Senior Vice President of Investor Relations |
| 8 | Ms. Jennifer L. Fox J.D. | Chief Legal Officer |
| 9 | Dr. Patrick M. Burke Ph.D. | Executive Vice President of Corporate & Business Development |
| 10 | Ms. Shereen Solaiman | Chief People Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 11,39% | 46,96 Mio. USD |
| 2 | Millennium Management LLC | 6,93% | 28,55 Mio. USD |
| 3 | Vestal Point Capital LP | 6,00% | 24,73 Mio. USD |
| 4 | State Street Corp | 5,21% | 21,50 Mio. USD |
| 5 | D. E. Shaw & Co LP | 4,79% | 19,76 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 4,27% | 17,60 Mio. USD |
| 7 | Acadian Asset Management LLC | 3,27% | 13,48 Mio. USD |
| 8 | Vanguard Portfolio Management, LLC | 3,22% | 13,28 Mio. USD |
| 9 | AQR Capital Management LLC | 2,89% | 11,93 Mio. USD |
| 10 | Morgan Stanley - Brokerage Accounts | 2,60% | 10,70 Mio. USD |
| 11 | Geode Capital Management, LLC | 2,53% | 10,42 Mio. USD |
| 12 | Assenagon Asset Management SA | 2,16% | 8,90 Mio. USD |
| 13 | The Goldman Sachs Group Inc | 2,15% | 8,87 Mio. USD |
| 14 | Jacobs Levy Equity Management, Inc. | 1,98% | 8,16 Mio. USD |
| 15 | Charles Schwab Investment Management Inc | 1,82% | 7,51 Mio. USD |
| 16 | Qube Research & Technologies | 1,74% | 7,18 Mio. USD |
| 17 | Federated Hermes Inc | 1,64% | 6,77 Mio. USD |
| 18 | Two Sigma Investments LLC | 1,63% | 6,72 Mio. USD |
| 19 | Nuveen, LLC | 1,62% | 6,67 Mio. USD |
| 20 | Mackenzie Investments | 1,61% | 6,62 Mio. USD |